Pharmacological targeting of NLRP3 deubiquitination for treatment of NLRP3-associated inflammatory diseases

Ren, GM; Li, J; Zhang, XC; Wang, Y; Xiao, Y; Zhang, XY; Liu, X; Zhang, W; Ma, WB; Zhang, J; Li, YT; Tao, SS; Wang, T; Liu, K; Chen, H; Zhan, YQ; Yu, M; Li, CY; Ge, CH; Tian, BX; Dou, GF; Yang, XM; Yin, RH

Yang, XM; Yin, RH (corresponding author), Beijing Inst Life, Natl Ctr Prot Sci Beijing, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing 102206, Peoples R China.; Yang, XM (corresponding author), Anhui Med Univ, Sch Basic Med Sci, Hefei 230032, Anhui, Peoples R China.

SCIENCE IMMUNOLOGY, 2021; 6 (58):

Abstract

Pharmacologically inhibiting nucleotide-binding domain and leucine-rich repeat-containing (NLR) family, pyrin domain-containing protein 3 (NLRP3) infl......

Full Text Link